IPHEX 2026 Opens Direct Pathways for Sri Lanka’s Healthcare Sector 📈

• Event Scale: The 12th International Exhibition on Pharma and Healthcare (IPHEX 2026) in New Delhi gathered ~900 Indian exhibitors and over 50,000 visitors. Organised by PHARMEXCIL, it covered the full pharmaceutical and healthcare spectrum, including APIs, formulations, vaccines, biosimilars, and surgical care. • Strategic Impact: As India supplies a major share of Sri Lanka’s pharmaceutical imports, direct access offers local importers and distributors sharper pricing and enhanced quality control through direct manufacturer relationships. • Local Industry Growth: Connects domestic players exploring contract manufacturing and export markets with technology providers, CROs, and joint-venture partners to bolster local R&D and supply chains. • Support for Delegates: Features a Hosted Buyer Program offering eligible overseas delegates economy airfare reimbursement and complimentary hotel stay, with tailored tracks for industry bodies and government procurement agencies.